BioHarvest Sciences IncBHST
Price$1.49

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value not published yet, our data-reliability standards weren't met; method estimates belowbased on filings through 31 Dec 2025
Market Price $1.49Price as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 1.6%/yr (balance of the path).2.3% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 61.9%Yr 72.2%Yr 82.4%Yr 92.7%Yr 103.0%
1.6% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)2.3%
Discount rate (cost of equity) 10.7%
Volatility vs market (adjusted beta)1.27

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetBioHarvest Sciences IncBHSTHealth Care
Valuation
P/E—
P/S1.1×
P/B1.5×
EV / Revenue0.4×
EV / EBITDA-14.6×
Profitability
Gross margin59.3%
Operating margin-16.2%
Net margin-32.3%
FCF margin-27.8%
Returns
ROE-43.8%
ROA-23.4%
ROIC—
Growth
Revenue growth (YoY)37.0%
5-yr fwd EPS growth—
Financial strength
Debt / Equity0.01×
Current ratio3.97×
Altman Z-Score-1.3
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.